Tapewire

Nasdaq · USD

TVTX

Travere Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1562
SEC CIK
0001438533
Parsed reports
437

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202506
Jan 202605
Feb 2026017
Mar 202601
Apr 2026023
May 2026015
Jun 202602
Jul 202600
Aug 202605
Sep 2026041
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 18, 2026 01:33 UTC
Inrig JulaEVP, Head of R&D & CMO
Exercise / conversionCommon Stock 32,395 $8.93 $289,287.35
Disclosure

SEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 1

Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
Exercise / conversionEmployee stock option (right to buy) · Derivative 37,500 $0.00 Strike: $15.46 $0.00
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · derivative · entry 6

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires 2030-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
SaleCommon Stock 300 $65.31 $19,593.00
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · nonDerivative · entry 5

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,389

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
SaleCommon Stock 1,400 $63.69 $89,166.28
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · nonDerivative · entry 4

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,689

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The weighted average sale price for the transaction reported was $63.6902, and the range of prices were between $63.59 and $63.85. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
SaleCommon Stock 13,874 $62.63 $868,964.69
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · nonDerivative · entry 3

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,089

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $62.6326, and the range of prices were between $62.44 and $63.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
SaleCommon Stock 21,926 $62.03 $1,359,971.11
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · nonDerivative · entry 2

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,963

F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $62.0255, and the range of prices were between $61.44 and $62.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:32 UTC
REED ELIZABETH EChief Legal Officer and GC
Exercise / conversionCommon Stock 37,500 $15.46 $579,750.00
Disclosure

SEC source: 0001283303-26-000010 · form4-09182026_010948.xml · nonDerivative · entry 1

REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 178 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 95,666 $0.00 Strike: $23.34 $0.00
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · derivative · entry 12

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 304,334

Underlying: Common Stock · 95,666 shares

Expires 2029-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 270 $65.31 $17,633.70
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 5

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 432,886

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 3,102 $63.64 $197,421.83
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 4

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 433,156

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $63.6434, and the range of prices were between $63.45 and $63.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 28,796 $62.66 $1,804,222.02
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 3

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 436,258

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $62.6553, and the range of prices were between $62.41 and $63.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 63,498 $61.99 $3,936,526.76
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 2

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 465,054

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The weighted average sale price for the transaction reported was $61.9945, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:31 UTC
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionCommon Stock 95,666 $23.34 $2,232,844.44
Disclosure

SEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 1

Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 528,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 20,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · derivative · entry 6

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
SaleCommon Stock 400 $65.31 $26,124.00
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · nonDerivative · entry 5

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,508

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
SaleCommon Stock 1,900 $63.69 $121,004.35
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · nonDerivative · entry 4

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,908

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F4 · price: The weighted average sale price for the transaction reported was $63.6865, and the range of prices were between $63.59 and $63.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
SaleCommon Stock 20,735 $62.61 $1,298,174.81
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · nonDerivative · entry 3

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,808

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F3 · price: The weighted average sale price for the transaction reported was $62.6079, and the range of prices were between $62.38 and $63.30. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
SaleCommon Stock 27,473 $62.00 $1,703,240.83
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · nonDerivative · entry 2

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,543

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F2 · price: The weighted average sale price for the transaction reported was $61.9969, and the range of prices were between $61.38 and $62.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:30 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 20,000 $17.44 $348,800.00
Disclosure

SEC source: 0001943192-26-000006 · form4-09182026_010929.xml · nonDerivative · entry 1

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 1,625 $0.00 Strike: $20.46 $0.00
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · derivative · entry 9

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,875

Underlying: Common Stock · 1,625 shares

Expires 2035-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: One-fourth of the shares subject to the stock option vested and become exercisable on the first anniversary of January 31, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 1,250 $0.00 Strike: $22.40 $0.00
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · derivative · entry 8

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 1,250 shares

Expires 2033-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionEmployee stock option (right to buy) · Derivative 2,500 $0.00 Strike: $27.50 $0.00
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · derivative · entry 7

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2032-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 300 $63.66 $19,098.99
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 6

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,353

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The weighted average sale price for the transaction reported was $63.6633, and the range of prices were between $63.64 and $63.71. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 800 $62.85 $50,278.48
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 5

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,653

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The weighted average sale price for the transaction reported was $62.8481, and the range of prices were between $62.62 and $63.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 4,275 $62.14 $265,627.13
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 4

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,453

F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The weighted average sale price for the transaction reported was $62.135, and the range of prices were between $61.53 and $62.51. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon Stock 1,625 $20.46 $33,247.50
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 3

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,728

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon Stock 1,250 $22.40 $28,000.00
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 2

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2026 Filed Sep 18, 2026 01:29 UTC
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon Stock 2,500 $27.50 $68,750.00
Disclosure

SEC source: 0001882909-26-000004 · form4-09182026_010916.xml · nonDerivative · entry 1

Calvin Sandra · CIK 0001882909 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC Exercise / conversionStock option (right to buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · derivative · entry 8

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC Exercise / conversionStock option (right to buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · derivative · entry 7

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC SaleCommon Stock 3,100 $68.09 $211,072.80
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 6

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,500

F1 · kind: This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028.

F5 · price: The weighted average sale price for the transaction reported was $68.088, and the range of prices were between $67.94 and $68.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC SaleCommon Stock 14,000 $67.46 $944,487.60
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 5

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,600

F1 · kind: This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028.

F4 · price: The weighted average sale price for the transaction reported was $67.4634, and the range of prices were between $66.93 and $67.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC SaleCommon Stock 1,200 $66.15 $79,380.00
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 4

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,600

F1 · kind: This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028.

F3 · price: The weighted average sale price for the transaction reported was $66.15, and the range of prices were between $65.93 and $66.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC SaleCommon Stock 1,700 $65.39 $111,165.89
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 3

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,800

F1 · kind: This sale was made pursuant to a written plan adopted on June 11, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person on May 17, 2017, with an expiration date of May 17, 2027, and on May 9, 2018, with an expiration date of May 9, 2028.

F2 · price: The weighted average sale price for the transaction reported was $65.3917, and the range of prices were between $64.835 and $65.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC Exercise / conversionCommon Stock 10,000 $26.52 $265,200.00
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 2

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2026 Filed Sep 11, 2026 20:05 UTC Exercise / conversionCommon Stock 10,000 $17.44 $174,400.00
Disclosure

SEC source: 0001506916-26-000004 · form4-09112026_040911.xml · nonDerivative · entry 1

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:05 UTC
Cline Christopher R.CHIEF FINANCIAL OFFICER
SaleCommon Stock 642 $66.37 $42,609.54
Disclosure

SEC source: 0001943192-26-000005 · form4-09032026_040908.xml · nonDerivative · entry 1

Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,016

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
Exercise / conversionStock option (right to buy) · Derivative 5,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · derivative · entry 9

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
SaleCommon Stock 900 $63.86 $57,470.13
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 7

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,500

F1 · kind: This sale was made pursuant to a written plan adopted on May 18, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F6 · price: The weighted average sale price for the transaction reported was $63.8557, and the range of prices were between $63.77 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
SaleCommon Stock 4,100 $63.27 $259,390.19
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 6

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,400

F1 · kind: This sale was made pursuant to a written plan adopted on May 18, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F5 · price: The weighted average sale price for the transaction reported was $63.2659, and the range of prices were between $62.76 and $63.69. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
Exercise / conversionCommon Stock 5,000 $17.44 $87,200.00
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 5

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
Exercise / conversionStock option (right to buy) · Derivative 5,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · derivative · entry 8

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2027-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
SaleCommon Stock 500 $64.16 $32,081.00
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 4

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,500

F1 · kind: This sale was made pursuant to a written plan adopted on May 18, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F4 · price: The weighted average sale price for the transaction reported was $64.1620, and the range of prices were between $64.04 and $64.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
SaleCommon Stock 2,600 $63.50 $165,099.74
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 3

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,000

F1 · kind: This sale was made pursuant to a written plan adopted on May 18, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F3 · price: The weighted average sale price for the transaction reported was $63.4999, and the range of prices were between $63.01 and $63.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
SaleCommon Stock 1,900 $62.53 $118,804.91
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,600

F1 · kind: This sale was made pursuant to a written plan adopted on May 18, 2026 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 17, 2027.

F2 · price: The weighted average sale price for the transaction reported was $62.5289, and the range of prices were between $62.00 and $62.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:05 UTC
LYONS GARY ADirector
Exercise / conversionCommon Stock 5,000 $17.44 $87,200.00
Disclosure

SEC source: 0001123343-26-000010 · form4-08192026_040801.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 22, 2026 Filed Jun 22, 2026 20:37 UTC
Inrig JulaCHIEF MEDICAL OFFICER
GiftCommon Stock 468 $0.00 $0.00
Disclosure

SEC source: 0001902368-26-000007 · form4-06222026_080607.xml · nonDerivative · entry 1

Inrig Jula · CIK 0001902368 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,770

F1 · kind: This transaction represents a bona fide gift of 468 shares of common stock to a donor-advised fund. The reporting person authorized the gift on June 16, 2026, and the transfer occurred on June 22, 2026.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:46 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001376043-26-000010 · form4-06162026_080644.xml · derivative · entry 3

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:46 UTC SaleCommon Stock 10,000 $50.07 $500,747.00
Disclosure

SEC source: 0001376043-26-000010 · form4-06162026_080644.xml · nonDerivative · entry 2

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,250

F1 · kind: This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The weighted average sale price for the transaction reported was $50.0747, and the range of prices were between $50.00 and $50.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:46 UTC Exercise / conversionCommon Stock 10,000 $26.52 $265,200.00
Disclosure

SEC source: 0001376043-26-000010 · form4-06162026_080644.xml · nonDerivative · entry 1

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.